185680.KS
185680.KS
Kodex SYNTH-US Biotech • Kodex
$39240.00 ▲ 0.32% (+125.00)
Managing Company Kodex
Asset Under Management $19.90B
Inception Date Oct 31, 2013
Expense Ratio 0.25%
52w High $40105.00
52w Low $21730.00
Volume 7,542
Avg Volume 8,950
Asset Class Equity
About Kodex SYNTH-US Biotech
KODEX Synth-US bio mainly focuses on USA's biotechnology companies committed to healthier future.
Managing Company Kodex
Asset Under Management $19.90B
Inception Date Oct 31, 2013
Expense Ratio 0.25%
52w High $40105.00
52w Low $21730.00
Volume 7,542
Avg Volume 8,950
Asset Class Equity
About Kodex SYNTH-US Biotech
KODEX Synth-US bio mainly focuses on USA's biotechnology companies committed to healthier future.
HOLDINGS (Top 20)
No holdings data available.
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Other
88.47%
United StatesSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Other
88.47% United StatesHoldings (Top 20)
No holdings data available.